STAT3 inhibition was also effective in treating the collagen-induced arthritis (CIA) RA model in vivo through significant reduction in expression of IL-6 family cytokines and RANKL, inhibiting both inflammation and joint destruction [209]. Here, IL6 is linked to rheumatoid arthritis.